IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

Verstockt, B., Salas, A., Sands, B.E., Abraham, C., Leibovitzh, H., Neurath, M.F., Casteele, N.V., Danese, S., D’Haens, G., Eckmann, L., Faubion, W.A., Feagan, B.G., Jairath, V., Ma, C., Mehandru, S., Panés, J., Rieder, F., Sandborn, W.J., Silverberg, M.S., &amp; Veny, M. (2023). IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. <em>Nature Reviews Gastroenterology & Hepatology</em>. https://doi.org/10.1038/s41575-023-00768-1

Verstockt B, Salas A, Sands BE, Abraham C, Leibovitzh H, Neurath MF, et al. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease. Nature Reviews Gastroenterology & Hepatology. 2023. doi:10.1038/s41575-023-00768-1.

@unpublished{bram2023ILandI, title = {IL-12 and IL-23 pathway inhibition in inflammatory bowel disease}, author = {Bram Verstockt and Azucena Salas and Bruce E. Sands and Clara Abraham and Haim Leibovitzh and Markus F. Neurath and Niels Vande Casteele and Silvio Danese and Geert D’Haens and Lars Eckmann and William A. Faubion and Brian G. Feagan and Vipul Jairath and Christopher Ma and Saurabh Mehandru and Julián Panés and Florian Rieder and William J. Sandborn and Mark S. Silverberg and Marisol Veny and Séverine Vermeire and Stefania Vetrano}, journal = {Nature Reviews Gastroenterology & Hepatology}, year = {2023}, doi = {10.1038/s41575-023-00768-1}, }